Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000863894-22-000013
Filing Date
2022-08-11
Accepted
2022-08-11 15:38:14
Documents
81
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q veru-20220630x10q.htm   iXBRL 10-Q 3239790
2 EX-10.1 veru-20220630xex10_1.htm EX-10.1 416722
3 EX-31.1 veru-20220630xex31_1.htm EX-31.1 15805
4 EX-31.2 veru-20220630xex31_2.htm EX-31.2 16030
5 EX-32.1 veru-20220630xex32_1.htm EX-32.1 11718
  Complete submission text file 0000863894-22-000013.txt   12968087

Data Files

Seq Description Document Type Size
6 EX-101.SCH veru-20220630.xsd EX-101.SCH 58954
7 EX-101.CAL veru-20220630_cal.xml EX-101.CAL 84036
8 EX-101.DEF veru-20220630_def.xml EX-101.DEF 195952
9 EX-101.LAB veru-20220630_lab.xml EX-101.LAB 473475
10 EX-101.PRE veru-20220630_pre.xml EX-101.PRE 393595
75 EXTRACTED XBRL INSTANCE DOCUMENT veru-20220630x10q_htm.xml XML 2998360
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

EIN.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 221155402
SIC: 2834 Pharmaceutical Preparations